Centro Medicina Primaria Vega Alta - Medicare Primary Care in Vega Alta, PR

Centro Medicina Primaria Vega Alta is a medicare enrolled primary clinic (General Practice) in Vega Alta, Puerto Rico. The current practice location for Centro Medicina Primaria Vega Alta is Carr 2 Km 31.9, Bo. Bajura, Vega Alta, Puerto Rico. For appointments, you can reach them via phone at (787) 883-0124. The mailing address for Centro Medicina Primaria Vega Alta is P.o. Box 4317, Vega Baja, Puerto Rico and phone number is (787) 883-0124.

Centro Medicina Primaria Vega Alta is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1184708448. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (787) 883-0124.

Contact Information

Centro Medicina Primaria Vega Alta
Carr 2 Km 31.9
Bo. Bajura
Vega Alta
PR 00692
(787) 883-0124
(787) 883-7645

Primary Care Clinic Profile

Full NameCentro Medicina Primaria Vega Alta
SpecialityGeneral Practice
LocationCarr 2 Km 31.9, Vega Alta, Puerto Rico
Authorized Official Name and PositionMildalias Dominguez Pascual (PRESIDENT)
Authorized Official Contact7878830124
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Centro Medicina Primaria Vega Alta
P.o. Box 4317
Vega Baja
PR 00694-4317

Ph: (787) 883-0124
Centro Medicina Primaria Vega Alta
Carr 2 Km 31.9
Bo. Bajura
Vega Alta
PR 00692

Ph: (787) 883-0124

NPI Details:

NPI Number1184708448
Provider Enumeration Date10/24/2006
Last Update Date02/25/2008

Medicare PECOS Information:

Medicare PECOS PAC ID2365405586
Medicare Enrollment IDO20041109000668

News Archive

Combination of Methotrexat and Tofacitinib shows promise against rheumatoid arthritis

Together with colleagues from the international rheumatic diseases research community, scientists of the Charité - Universitätsmedizin Berlin have presented a new therapy approach for the treatment of rheumatoid arthritis (RA), a chronic form of joint inflammation.

Edematous severe acute malnutrition linked to DNA modification

A group led by researchers at Baylor College of Medicine has identified significant differences at the epigenetic level - the chemical tags in DNA that help regulate gene expression - between two clinically distinct forms of acute childhood malnutrition known as edematous severe acute malnutrition (ESAM) and non-edematous SAM (NESAM).

FDA grants Teleflex 510(k) clearance for ArrowEVOLUTION PICC with Chlorag+ard technology

Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.

Early intervention can achieve better results for patients with rheumatoid arthritis

The cause of rheumatoid arthritis might still be unknown, but an understanding of its pathological processes has advanced greatly in the last 20 years.

Caregivers under financial and emotional strain

Family members or friends caring for aging or disabled individuals in California are under both financial and emotional strain and are likely to face even greater burdens, given recent cuts in state support for programs and services that support in-home care, write the authors of a new policy brief by the UCLA Center for Health Policy Research.

Read more Medical News

› Verified 9 days ago

Medical Identifiers

Medical identifiers for Centro Medicina Primaria Vega Alta such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1184708448NPI-NPPES
19197OtherPRTRIPLE S

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208D00000XGeneral Practice (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Centro Medicina Primaria Vega Alta acts as a billing entity for following providers:
Provider NameReinaldo Rios Rodriguez
Provider TypePractitioner - General Practice
Provider IdentifiersNPI Number: 1063631901
PECOS PAC ID: 7012982820
Enrollment ID: I20040826000453

News Archive

Combination of Methotrexat and Tofacitinib shows promise against rheumatoid arthritis

Together with colleagues from the international rheumatic diseases research community, scientists of the Charité - Universitätsmedizin Berlin have presented a new therapy approach for the treatment of rheumatoid arthritis (RA), a chronic form of joint inflammation.

Edematous severe acute malnutrition linked to DNA modification

A group led by researchers at Baylor College of Medicine has identified significant differences at the epigenetic level - the chemical tags in DNA that help regulate gene expression - between two clinically distinct forms of acute childhood malnutrition known as edematous severe acute malnutrition (ESAM) and non-edematous SAM (NESAM).

FDA grants Teleflex 510(k) clearance for ArrowEVOLUTION PICC with Chlorag+ard technology

Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.

Early intervention can achieve better results for patients with rheumatoid arthritis

The cause of rheumatoid arthritis might still be unknown, but an understanding of its pathological processes has advanced greatly in the last 20 years.

Caregivers under financial and emotional strain

Family members or friends caring for aging or disabled individuals in California are under both financial and emotional strain and are likely to face even greater burdens, given recent cuts in state support for programs and services that support in-home care, write the authors of a new policy brief by the UCLA Center for Health Policy Research.

Read more Medical News

› Verified 9 days ago

Provider NameFernando A Garcia Cruz
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1316041809
PECOS PAC ID: 2163485392
Enrollment ID: I20100423000305

News Archive

Combination of Methotrexat and Tofacitinib shows promise against rheumatoid arthritis

Together with colleagues from the international rheumatic diseases research community, scientists of the Charité - Universitätsmedizin Berlin have presented a new therapy approach for the treatment of rheumatoid arthritis (RA), a chronic form of joint inflammation.

Edematous severe acute malnutrition linked to DNA modification

A group led by researchers at Baylor College of Medicine has identified significant differences at the epigenetic level - the chemical tags in DNA that help regulate gene expression - between two clinically distinct forms of acute childhood malnutrition known as edematous severe acute malnutrition (ESAM) and non-edematous SAM (NESAM).

FDA grants Teleflex 510(k) clearance for ArrowEVOLUTION PICC with Chlorag+ard technology

Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.

Early intervention can achieve better results for patients with rheumatoid arthritis

The cause of rheumatoid arthritis might still be unknown, but an understanding of its pathological processes has advanced greatly in the last 20 years.

Caregivers under financial and emotional strain

Family members or friends caring for aging or disabled individuals in California are under both financial and emotional strain and are likely to face even greater burdens, given recent cuts in state support for programs and services that support in-home care, write the authors of a new policy brief by the UCLA Center for Health Policy Research.

Read more Medical News

› Verified 9 days ago

Provider NameKareen T Tirado
Provider TypePractitioner - General Practice
Provider IdentifiersNPI Number: 1811933633
PECOS PAC ID: 4981870433
Enrollment ID: I20120104000497

News Archive

Combination of Methotrexat and Tofacitinib shows promise against rheumatoid arthritis

Together with colleagues from the international rheumatic diseases research community, scientists of the Charité - Universitätsmedizin Berlin have presented a new therapy approach for the treatment of rheumatoid arthritis (RA), a chronic form of joint inflammation.

Edematous severe acute malnutrition linked to DNA modification

A group led by researchers at Baylor College of Medicine has identified significant differences at the epigenetic level - the chemical tags in DNA that help regulate gene expression - between two clinically distinct forms of acute childhood malnutrition known as edematous severe acute malnutrition (ESAM) and non-edematous SAM (NESAM).

FDA grants Teleflex 510(k) clearance for ArrowEVOLUTION PICC with Chlorag+ard technology

Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.

Early intervention can achieve better results for patients with rheumatoid arthritis

The cause of rheumatoid arthritis might still be unknown, but an understanding of its pathological processes has advanced greatly in the last 20 years.

Caregivers under financial and emotional strain

Family members or friends caring for aging or disabled individuals in California are under both financial and emotional strain and are likely to face even greater burdens, given recent cuts in state support for programs and services that support in-home care, write the authors of a new policy brief by the UCLA Center for Health Policy Research.

Read more Medical News

› Verified 9 days ago

Provider NameElvira Perez Perez
Provider TypePractitioner - General Practice
Provider IdentifiersNPI Number: 1902139587
PECOS PAC ID: 7618136722
Enrollment ID: I20120309000076

News Archive

Combination of Methotrexat and Tofacitinib shows promise against rheumatoid arthritis

Together with colleagues from the international rheumatic diseases research community, scientists of the Charité - Universitätsmedizin Berlin have presented a new therapy approach for the treatment of rheumatoid arthritis (RA), a chronic form of joint inflammation.

Edematous severe acute malnutrition linked to DNA modification

A group led by researchers at Baylor College of Medicine has identified significant differences at the epigenetic level - the chemical tags in DNA that help regulate gene expression - between two clinically distinct forms of acute childhood malnutrition known as edematous severe acute malnutrition (ESAM) and non-edematous SAM (NESAM).

FDA grants Teleflex 510(k) clearance for ArrowEVOLUTION PICC with Chlorag+ard technology

Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.

Early intervention can achieve better results for patients with rheumatoid arthritis

The cause of rheumatoid arthritis might still be unknown, but an understanding of its pathological processes has advanced greatly in the last 20 years.

Caregivers under financial and emotional strain

Family members or friends caring for aging or disabled individuals in California are under both financial and emotional strain and are likely to face even greater burdens, given recent cuts in state support for programs and services that support in-home care, write the authors of a new policy brief by the UCLA Center for Health Policy Research.

Read more Medical News

› Verified 9 days ago

Provider NameVivian Lopez Lorenzo
Provider TypePractitioner - General Practice
Provider IdentifiersNPI Number: 1235229048
PECOS PAC ID: 1254591480
Enrollment ID: I20120327000269

News Archive

Combination of Methotrexat and Tofacitinib shows promise against rheumatoid arthritis

Together with colleagues from the international rheumatic diseases research community, scientists of the Charité - Universitätsmedizin Berlin have presented a new therapy approach for the treatment of rheumatoid arthritis (RA), a chronic form of joint inflammation.

Edematous severe acute malnutrition linked to DNA modification

A group led by researchers at Baylor College of Medicine has identified significant differences at the epigenetic level - the chemical tags in DNA that help regulate gene expression - between two clinically distinct forms of acute childhood malnutrition known as edematous severe acute malnutrition (ESAM) and non-edematous SAM (NESAM).

FDA grants Teleflex 510(k) clearance for ArrowEVOLUTION PICC with Chlorag+ard technology

Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.

Early intervention can achieve better results for patients with rheumatoid arthritis

The cause of rheumatoid arthritis might still be unknown, but an understanding of its pathological processes has advanced greatly in the last 20 years.

Caregivers under financial and emotional strain

Family members or friends caring for aging or disabled individuals in California are under both financial and emotional strain and are likely to face even greater burdens, given recent cuts in state support for programs and services that support in-home care, write the authors of a new policy brief by the UCLA Center for Health Policy Research.

Read more Medical News

› Verified 9 days ago

Provider NameJose Luis Alvarez
Provider TypePractitioner - General Practice
Provider IdentifiersNPI Number: 1568846590
PECOS PAC ID: 5799094033
Enrollment ID: I20151027002365

News Archive

Combination of Methotrexat and Tofacitinib shows promise against rheumatoid arthritis

Together with colleagues from the international rheumatic diseases research community, scientists of the Charité - Universitätsmedizin Berlin have presented a new therapy approach for the treatment of rheumatoid arthritis (RA), a chronic form of joint inflammation.

Edematous severe acute malnutrition linked to DNA modification

A group led by researchers at Baylor College of Medicine has identified significant differences at the epigenetic level - the chemical tags in DNA that help regulate gene expression - between two clinically distinct forms of acute childhood malnutrition known as edematous severe acute malnutrition (ESAM) and non-edematous SAM (NESAM).

FDA grants Teleflex 510(k) clearance for ArrowEVOLUTION PICC with Chlorag+ard technology

Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.

Early intervention can achieve better results for patients with rheumatoid arthritis

The cause of rheumatoid arthritis might still be unknown, but an understanding of its pathological processes has advanced greatly in the last 20 years.

Caregivers under financial and emotional strain

Family members or friends caring for aging or disabled individuals in California are under both financial and emotional strain and are likely to face even greater burdens, given recent cuts in state support for programs and services that support in-home care, write the authors of a new policy brief by the UCLA Center for Health Policy Research.

Read more Medical News

› Verified 9 days ago

Provider NameGlorymar Ortiz Cordero
Provider TypePractitioner - Pediatric Medicine
Provider IdentifiersNPI Number: 1295143758
PECOS PAC ID: 6901168871
Enrollment ID: I20180313002367

News Archive

Combination of Methotrexat and Tofacitinib shows promise against rheumatoid arthritis

Together with colleagues from the international rheumatic diseases research community, scientists of the Charité - Universitätsmedizin Berlin have presented a new therapy approach for the treatment of rheumatoid arthritis (RA), a chronic form of joint inflammation.

Edematous severe acute malnutrition linked to DNA modification

A group led by researchers at Baylor College of Medicine has identified significant differences at the epigenetic level - the chemical tags in DNA that help regulate gene expression - between two clinically distinct forms of acute childhood malnutrition known as edematous severe acute malnutrition (ESAM) and non-edematous SAM (NESAM).

FDA grants Teleflex 510(k) clearance for ArrowEVOLUTION PICC with Chlorag+ard technology

Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.

Early intervention can achieve better results for patients with rheumatoid arthritis

The cause of rheumatoid arthritis might still be unknown, but an understanding of its pathological processes has advanced greatly in the last 20 years.

Caregivers under financial and emotional strain

Family members or friends caring for aging or disabled individuals in California are under both financial and emotional strain and are likely to face even greater burdens, given recent cuts in state support for programs and services that support in-home care, write the authors of a new policy brief by the UCLA Center for Health Policy Research.

Read more Medical News

› Verified 9 days ago

Provider NameGerardo Jose Lopez-cepero
Provider TypePractitioner - General Practice
Provider IdentifiersNPI Number: 1366914350
PECOS PAC ID: 0446670673
Enrollment ID: I20201008003319

News Archive

Combination of Methotrexat and Tofacitinib shows promise against rheumatoid arthritis

Together with colleagues from the international rheumatic diseases research community, scientists of the Charité - Universitätsmedizin Berlin have presented a new therapy approach for the treatment of rheumatoid arthritis (RA), a chronic form of joint inflammation.

Edematous severe acute malnutrition linked to DNA modification

A group led by researchers at Baylor College of Medicine has identified significant differences at the epigenetic level - the chemical tags in DNA that help regulate gene expression - between two clinically distinct forms of acute childhood malnutrition known as edematous severe acute malnutrition (ESAM) and non-edematous SAM (NESAM).

FDA grants Teleflex 510(k) clearance for ArrowEVOLUTION PICC with Chlorag+ard technology

Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.

Early intervention can achieve better results for patients with rheumatoid arthritis

The cause of rheumatoid arthritis might still be unknown, but an understanding of its pathological processes has advanced greatly in the last 20 years.

Caregivers under financial and emotional strain

Family members or friends caring for aging or disabled individuals in California are under both financial and emotional strain and are likely to face even greater burdens, given recent cuts in state support for programs and services that support in-home care, write the authors of a new policy brief by the UCLA Center for Health Policy Research.

Read more Medical News

› Verified 9 days ago

Provider NameJoseph Anthony Mendez Gomez
Provider TypePractitioner - General Practice
Provider IdentifiersNPI Number: 1316591548
PECOS PAC ID: 8820418981
Enrollment ID: I20201012002527

News Archive

Combination of Methotrexat and Tofacitinib shows promise against rheumatoid arthritis

Together with colleagues from the international rheumatic diseases research community, scientists of the Charité - Universitätsmedizin Berlin have presented a new therapy approach for the treatment of rheumatoid arthritis (RA), a chronic form of joint inflammation.

Edematous severe acute malnutrition linked to DNA modification

A group led by researchers at Baylor College of Medicine has identified significant differences at the epigenetic level - the chemical tags in DNA that help regulate gene expression - between two clinically distinct forms of acute childhood malnutrition known as edematous severe acute malnutrition (ESAM) and non-edematous SAM (NESAM).

FDA grants Teleflex 510(k) clearance for ArrowEVOLUTION PICC with Chlorag+ard technology

Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.

Early intervention can achieve better results for patients with rheumatoid arthritis

The cause of rheumatoid arthritis might still be unknown, but an understanding of its pathological processes has advanced greatly in the last 20 years.

Caregivers under financial and emotional strain

Family members or friends caring for aging or disabled individuals in California are under both financial and emotional strain and are likely to face even greater burdens, given recent cuts in state support for programs and services that support in-home care, write the authors of a new policy brief by the UCLA Center for Health Policy Research.

Read more Medical News

› Verified 9 days ago

Provider NameLorenzo Rivera
Provider TypePractitioner - General Practice
Provider IdentifiersNPI Number: 1730814021
PECOS PAC ID: 4880063080
Enrollment ID: I20221209002683

News Archive

Combination of Methotrexat and Tofacitinib shows promise against rheumatoid arthritis

Together with colleagues from the international rheumatic diseases research community, scientists of the Charité - Universitätsmedizin Berlin have presented a new therapy approach for the treatment of rheumatoid arthritis (RA), a chronic form of joint inflammation.

Edematous severe acute malnutrition linked to DNA modification

A group led by researchers at Baylor College of Medicine has identified significant differences at the epigenetic level - the chemical tags in DNA that help regulate gene expression - between two clinically distinct forms of acute childhood malnutrition known as edematous severe acute malnutrition (ESAM) and non-edematous SAM (NESAM).

FDA grants Teleflex 510(k) clearance for ArrowEVOLUTION PICC with Chlorag+ard technology

Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.

Early intervention can achieve better results for patients with rheumatoid arthritis

The cause of rheumatoid arthritis might still be unknown, but an understanding of its pathological processes has advanced greatly in the last 20 years.

Caregivers under financial and emotional strain

Family members or friends caring for aging or disabled individuals in California are under both financial and emotional strain and are likely to face even greater burdens, given recent cuts in state support for programs and services that support in-home care, write the authors of a new policy brief by the UCLA Center for Health Policy Research.

Read more Medical News

› Verified 9 days ago

Provider NameKeysha Karelis Reyes Olivo
Provider TypePractitioner - General Practice
Provider IdentifiersNPI Number: 1386392793
PECOS PAC ID: 4284004169
Enrollment ID: I20230111000291

News Archive

Combination of Methotrexat and Tofacitinib shows promise against rheumatoid arthritis

Together with colleagues from the international rheumatic diseases research community, scientists of the Charité - Universitätsmedizin Berlin have presented a new therapy approach for the treatment of rheumatoid arthritis (RA), a chronic form of joint inflammation.

Edematous severe acute malnutrition linked to DNA modification

A group led by researchers at Baylor College of Medicine has identified significant differences at the epigenetic level - the chemical tags in DNA that help regulate gene expression - between two clinically distinct forms of acute childhood malnutrition known as edematous severe acute malnutrition (ESAM) and non-edematous SAM (NESAM).

FDA grants Teleflex 510(k) clearance for ArrowEVOLUTION PICC with Chlorag+ard technology

Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.

Early intervention can achieve better results for patients with rheumatoid arthritis

The cause of rheumatoid arthritis might still be unknown, but an understanding of its pathological processes has advanced greatly in the last 20 years.

Caregivers under financial and emotional strain

Family members or friends caring for aging or disabled individuals in California are under both financial and emotional strain and are likely to face even greater burdens, given recent cuts in state support for programs and services that support in-home care, write the authors of a new policy brief by the UCLA Center for Health Policy Research.

Read more Medical News

› Verified 9 days ago

News Archive

Combination of Methotrexat and Tofacitinib shows promise against rheumatoid arthritis

Together with colleagues from the international rheumatic diseases research community, scientists of the Charité - Universitätsmedizin Berlin have presented a new therapy approach for the treatment of rheumatoid arthritis (RA), a chronic form of joint inflammation.

Edematous severe acute malnutrition linked to DNA modification

A group led by researchers at Baylor College of Medicine has identified significant differences at the epigenetic level - the chemical tags in DNA that help regulate gene expression - between two clinically distinct forms of acute childhood malnutrition known as edematous severe acute malnutrition (ESAM) and non-edematous SAM (NESAM).

FDA grants Teleflex 510(k) clearance for ArrowEVOLUTION PICC with Chlorag+ard technology

Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.

Early intervention can achieve better results for patients with rheumatoid arthritis

The cause of rheumatoid arthritis might still be unknown, but an understanding of its pathological processes has advanced greatly in the last 20 years.

Caregivers under financial and emotional strain

Family members or friends caring for aging or disabled individuals in California are under both financial and emotional strain and are likely to face even greater burdens, given recent cuts in state support for programs and services that support in-home care, write the authors of a new policy brief by the UCLA Center for Health Policy Research.

Read more News

› Verified 9 days ago


General Practice in Vega Alta, PR

Clinica Georgetti Inc.
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 58 Calle Georgetti, Vega Alta, PR 00692
Phone: 787-883-1379    Fax: 787-883-1360
Cf Medical Services
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: Estancias De Cerro Gordo, 96 Plaza Carmen, Vega Alta, PR 00692
Phone: 787-308-3566    Fax: 787-915-7386
Gemelle Medical Services Psc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: Carr. #2 Km 30 Sector Espinosa 17-d, Vega Alta, PR 00692
Phone: 787-915-6224    Fax: 787-915-6223
Salud Directa De Puerto Rico
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: Calle Luis Munoz Rivera #3, Vega Alta, PR 00692
Phone: 787-883-0124    Fax: 787-883-0222
Dr Gustavo Cedeno Quintero Psc
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 58 Calle Eduardo Georgetti, Vega Alta, PR 00692
Phone: 787-484-5103    
Angelorum, Inc.
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: Carr 693 Km 13.8, Suite 171 Bo Brenas, Vega Alta, PR 00692
Phone: 787-270-3330    Fax: 787-915-7594

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.